Relmada Therapeutics Inc
NASDAQ:RLMD
Relmada Therapeutics Inc
NASDAQ:RLMD
Price:
7.26
USD
1.26%
Market Closed
Market Cap:
$761.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
Copenhagen Airports A/S
CSE:KBHL
|
DK |
|
W
|
WEYCO Group Inc
NASDAQ:WEYS
|
US |
|
Community Health Systems Inc
NYSE:CYH
|
US |
|
Konami Holdings Corp
TSE:9766
|
JP |
|
Mesoblast Ltd
ASX:MSB
|
AU |
|
Nucor Corp
NYSE:NUE
|
US |
|
ICL Group Ltd
TASE:ICL
|
IL |
|
Keppel REIT
SGX:K71U
|
SG |
Multiples-Based Value
The Multiples-Based Value for Relmada Therapeutics Inc (RLMD) under the Base Case is hidden
USD.
Compared with the current market price of 7.26 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RLMD Multiples-Based Value
LOCKED
